BlackRock’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-297,433
| Closed | -$1.88M | – | 5782 |
|
|
2022
Q4 | $1.88M | Sell |
297,433
-370
| -0.1% | -$2.05K | ﹤0.01% | 4160 |
|
|
2022
Q3 | $1.52M | Buy |
297,803
+950
| +0.3% | +$5.96K | ﹤0.01% | 4317 |
|
|
2022
Q2 | $1.86M | Buy |
296,853
+906
| +0.3% | +$3.05K | ﹤0.01% | 4280 |
|
|
2022
Q1 | $1.05M | Buy |
295,947
+4,776
| +2% | +$17.6K | ﹤0.01% | 4650 |
|
|
2021
Q4 | $1.46M | Buy |
291,171
+1,783
| +0.6% | +$10.8K | ﹤0.01% | 4522 |
|
|
2021
Q3 | $2.12M | Buy |
289,388
+638
| +0.2% | +$4.38K | ﹤0.01% | 4301 |
|
|
2021
Q2 | $2.48M | Buy |
288,750
+244,227
| +549% | +$2.08M | ﹤0.01% | 4168 |
|
|
2021
Q1 | $482K | Sell |
44,523
-297
| -0.7% | -$2.88K | ﹤0.01% | 4615 |
|
|
2020
Q4 | $443K | Sell |
44,820
-1,057
| -2% | -$6.92K | ﹤0.01% | 4369 |
|
|
2020
Q3 | $245K | Buy |
45,877
+4
| +0% | +$24 | ﹤0.01% | 4375 |
|
|
2020
Q2 | $270K | Sell |
45,873
-8,371
| -15% | -$48.4K | ﹤0.01% | 4317 |
|
|
2020
Q1 | $201K | Buy |
54,244
+465
| +0.9% | +$2.41K | ﹤0.01% | 4226 |
|
|
2019
Q4 | $340K | Buy |
53,779
+1,573
| +3% | +$20K | ﹤0.01% | 4230 |
|
|
2019
Q3 | $718K | Buy |
52,206
+1,313
| +3% | +$21.6K | ﹤0.01% | 4083 |
|
|
2019
Q2 | $751K | Sell |
50,893
-120,339
| -70% | -$3.22M | ﹤0.01% | 4099 |
|
|
2019
Q1 | $7.18M | Buy |
171,232
+2,399
| +1% | +$101K | ﹤0.01% | 3264 |
|
|
2018
Q4 | $7.02M | Buy |
168,833
+17,816
| +12% | +$801K | ﹤0.01% | 3260 |
|
|
2018
Q3 | $7.28M | Buy |
151,017
+30,202
| +25% | +$1.51M | ﹤0.01% | 3372 |
|
|
2018
Q2 | $5.73M | Buy |
120,815
+113,258
| +1,499% | +$6.28M | ﹤0.01% | 3465 |
|
|
2018
Q1 | $465K | Sell |
7,557
-683
| -8% | -$36K | ﹤0.01% | 4060 |
|
|
2017
Q4 | $443K | Buy |
8,240
+1,064
| +15% | +$63.3K | ﹤0.01% | 4073 |
|
|
2017
Q3 | $483K | Buy |
7,176
+1,847
| +35% | +$106K | ﹤0.01% | 4067 |
|
|
2017
Q2 | $288K | Buy |
5,329
+5,288
| +12,898% | +$245K | ﹤0.01% | 4162 |
|
|
2017
Q1 | $1K | Buy |
+41
| New | +$1.41K | ﹤0.01% | 4982 |
|
BlackRock's FSTX Position: Q1 2023 in Review
BlackRock sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 297,433 shares — an estimated $1.88M sold.
BlackRock first reported a position in FSTX in Q1 2017 and held it in 24 quarters. The position peaked at $7.28M in Q3 2018. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.
- BlackRock reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- BlackRock sold 297,433 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $1.88M.
- BlackRock first reported a position in F-star Therapeutics, Inc. Common Stock in Q1 2017 and held it in 24 quarters.
- BlackRock's F-star Therapeutics, Inc. Common Stock position peaked at $7.28M in Q3 2018.
- 0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.
Based on BlackRock's 13F filing for Q1 2023, filed 12 May 2023.